The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease-Reference-Cited by-同舟云学术

The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease

Published:2019-07 Issue:3 Volume:9 Page:1-11
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Li Gang¹^ORCID,Zhang Han¹,Zhao Lei²,Zhang Yaozhong¹,Yan Daole¹,Liu Yinglong¹,Su Junwu¹,Fan Xiangming¹

Affiliation:

1. Pediatric Cardiac CenterBeijing Anzhen HospitalCapital Medical UniversityBeijing Institute of Heart Lung and Blood Vessel DiseasesBeijingChina

2. Department of Molecular Physiology and BiophysicsHolden Comprehensive Cancer CenterUniversity of Iowa Carver College of MedicineIowa CityIAUSA

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Beijing Municipal Administration of Hospitals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019859480

Reference29 articles.

1. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease;Van d Feen DE;Eur Heart J,2017

2. Adaptation and Remodelling of the Pulmonary Circulation in Pulmonary Hypertension

3. Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials

4. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

5. Apoptosis‐based therapy to treat pulmonary arterial hypertension;Suzuki YJ;J Rare Dis Res Treat,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Pulmonary Hypertension Associated with Congenital Heart Disease and Their Significance;Advances in Clinical Medicine;2024

2. Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension;Current Vascular Pharmacology;2023-12-19

3. Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension;Frontiers in Pharmacology;2023-04-24

4. Pulmonary arterial hypertension associated with congenital heart disease: An omics study;Frontiers in Cardiovascular Medicine;2023-03-10

5. Oscillatory shear stress promotes vein graft intimal hyperplasia via NADPH oxidase-related pathways;Frontiers in Surgery;2023-02-13